Heart failure patients monitored on dapagliflozin in Real-World study

NCT ID NCT05635331

First seen Jan 03, 2026 · Last updated May 14, 2026 · Updated 23 times

Summary

This study followed 257 adults with heart failure who were prescribed dapagliflozin. Researchers wanted to see how patients used the medication in everyday life and how their quality of life changed. The goal was to gather real-world information, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Alexandroupoli, 68100, Greece

  • Research Site

    Athens, 11526, Greece

  • Research Site

    Athens, 11527, Greece

  • Research Site

    Athens, 11528, Greece

  • Research Site

    Athens, 12462, Greece

  • Research Site

    Athens, 14233, Greece

  • Research Site

    Athens, 17674, Greece

  • Research Site

    Chania, 73300, Greece

  • Research Site

    Heraklion, 71409, Greece

  • Research Site

    Ioannina, 45445, Greece

  • Research Site

    Ioannina, 45500, Greece

  • Research Site

    Pátrai, 26504, Greece

  • Research Site

    Thessaloniki, 54636, Greece

  • Research Site

    Thessaloniki, 54642, Greece

  • Research Site

    Thessaloniki, 56429, Greece

  • Research Site

    Thessaloniki, 57010, Greece

Conditions

Explore the condition pages connected to this study.